Analysts consider potential Qiagen deal amid reported strategic review
Go back to Analysts consider potential Qiagen deal amid reported strategic review| Agilent Technologies Inc (NYSE: A) | Delayed: 148.44 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $148.44 | 52 Week High | $48.63 | |||
| Open | $148.44 | 52 Week Low | $34.15 | |||
| Day High | $148.44 | P/E | 68.72 | |||
| Day Low | $148.44 | EPS | $2.16 | |||
| Volume | 10 | |||||
| Danaher Corp. (NYSE: DHR) | Delayed: 199.58 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $199.58 | 52 Week High | $102.79 | |||
| Open | $199.58 | 52 Week Low | $75.71 | |||
| Day High | $199.58 | P/E | 52.52 | |||
| Day Low | $199.58 | EPS | $3.80 | |||
| Volume | 70 | |||||
| Hologic, Inc. (NASDAQ: HOLX) | Delayed: 76.01 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $76.01 | 52 Week High | $41.66 | |||
| Open | $76.01 | 52 Week Low | $31.84 | |||
| Day High | $76.01 | P/E | N/A | |||
| Day Low | $76.01 | EPS | $-4.40 | |||
| Volume | 1,081 | |||||
| Qiagen NV (NYSE: QGEN) | Delayed: 42.32 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $42.32 | 52 Week High | $28.50 | |||
| Open | $42.32 | 52 Week Low | $19.94 | |||
| Day High | $42.32 | P/E | 145.93 | |||
| Day Low | $42.32 | EPS | $0.29 | |||
| Volume | 1,770 | |||||
| (NYSE: QIA) | Delayed: 0.00 -10.35 (100%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.35 | 52 Week High | $ | |||
| Open | $10.35 | 52 Week Low | $ | |||
| Day High | $10.35 | P/E | N/A | |||
| Day Low | $10.35 | EPS | $ | |||
| Volume | 0 | |||||
| Thermo Fisher Scientific (NYSE: TMO) | Delayed: 589.04 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $589.04 | 52 Week High | $160.68 | |||
| Open | $589.04 | 52 Week Low | $119.75 | |||
| Day High | $589.04 | P/E | 168.30 | |||
| Day Low | $589.04 | EPS | $3.50 | |||
| Volume | 116 | |||||

